Skip to main content
BOSTON SCIENTIFIC CORP logo

BOSTON SCIENTIFIC CORP — Investor Relations & Filings

Ticker · BSX ISIN · US1011371077 LEI · Y6ZDD9FP4P8JSSJMW954 US Manufacturing
Open in API
Filings indexed 3,157 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country US United States of America
Listing US BSX

About BOSTON SCIENTIFIC CORP

https://www.bostonscientific.com/en-US/…

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and commercializes a broad range of high-performance medical devices. The company's products are used in various minimally invasive, interventional medical specialties, including cardiology, endoscopy, neuromodulation, urology, and pelvic health. Focused on transforming lives through innovative solutions, Boston Scientific is dedicated to improving the health of patients worldwide by addressing complex healthcare challenges and enhancing clinical outcomes.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings Classification · 90% confidence The document is a U.S. SEC Form SD (Specialized Disclosure Report) for conflict minerals. It is a regulatory compliance filing under Rule 13p-1 of the Securities Exchange Act, providing specialized disclosure rather than containing substantive financial statements or an announcement of a general report. This falls under the general regulatory filings category (RNS) as a compliance document.
2026-05-21 English
8-K
Transaction in Own Shares Classification · 91% confidence The document is a Form 8-K current report announcing an accelerated share repurchase (ASR) agreement – the company is buying back its own shares. This fits the definition of a “Transaction in Own Shares” (share repurchase). Hence, it is classified under code POS.
2026-05-18 English
8-K
Capital/Financing Update Classification · 82% confidence The document is a Form 8-K “Current Report” announcing an investment agreement by Boston Scientific—an equity purchase for $1.5 billion plus options to acquire additional interests (call option)—and is not a full annual or quarterly report. It is not a proxy statement, earnings release, or governance update, nor is it a certification. It details a financing/investment transaction, so it best fits Capital/Financing Update (CAP).
2026-05-18 English
FORM S-8
Share Issue/Capital Change Classification · 96% confidence The document is an SEC Registration Statement on Form S-8 for Boston Scientific Corporation’s Employee Stock Purchase Plan, registering 10,000,000 shares of common stock under that plan. A Form S-8 is by definition a share registration/issuance filing. Under our taxonomy, this corresponds to Share Issue/Capital Change (SHA).
2026-05-08 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-06 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is a Form 8-K from Boston Scientific reporting (1) charter amendments effective May 5, 2026, and (2) detailed voting results from the April 30, 2026 Annual Meeting (Item 5.07). It provides final vote tallies for director elections and proposals, fitting the definition of a Declaration of Voting Results filing. Hence, the appropriate classification is DVA.
2026-05-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.